CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study

• Main Authors: Nicola I. Lorè (Author), Rebecca De Lorenzo (Author), Paola M. V. Rancoita (Author), Federica Cugnata (Author), Alessandra Agresti (Author), Francesco Benedetti (Author), Marco E. Bianchi (Author), Chiara Bonini (Author), Annalisa Capobianco (Author), Caterina Conte (Author), Angelo Corti (Author), Roberto Furlan (Author), Paola Mantegani (Author), Norma Maugeri (Author), Clara Sciorati (Author), Fabio Saliu (Author), Laura Silvestri (Author), Cristina Tresoldi (Author), Bio Angels for COVID-BioB Study Group (Author), Fabio Ciceri (Author), Patrizia Rovere-Querini (Author), Clelia Di Serio (Author), Daniela M. Cirillo (Author), Angelo A. Manfredi (Author)
• Format: Book
• Published: BMC, 2021-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Host inflammation contributes to determine whether SARS-CoV-2 infection causes mild or life-threatening disease. Tools are needed for early risk assessment. Methods We studied in 111 COVID-19 patients prospectively followed at a single reference Hospital fifty-three potential bio...